Bond AbbVie Inc. 4.85% ( USU0029QBF29 ) in USD
| Issuer | AbbVie Inc. |
| Market price | |
| Country | United States
|
| ISIN code |
USU0029QBF29 ( in USD )
|
| Interest rate | 4.85% per year ( payment 2 times a year) |
| Maturity | 15/06/2044 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 008 583 000 USD |
| Cusip | U0029QBF2 |
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) |
| Moody's rating | N/A |
| Next Coupon | 15/12/2025 ( In 40 days ) |
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code USU0029QBF29, pays a coupon of 4.85% per year. The coupons are paid 2 times per year and the Bond maturity is 15/06/2044 The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code USU0029QBF29, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States